AIM Immunotech
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • CEO Corner
    • Partnering
  • Science
    • Pipeline
    • Ampligen®
    • Immuno-Oncology
    • Immune Disorders
    • Viral Diseases
    • Orphan Drug Designation
    • Scientific Publications
  • Investors
    • Overview
    • Press Releases
    • Company Info
      • Profile
      • Management Team
    • Presentations
    • Events
    • Stock Information
    • SEC Filings
    • Analyst Coverage
    • Corporate Governance
      • Governance Documents
      • Board of Directors
      • Committee Composition
    • Stockholder Meeting
    • Email Alerts
    • Investor Contact
  • Contact Us
Select Page
  • Overview
  • Press Releases
  • Company Info
    • Profile
    • Management Team
  • Presentations
  • Events
  • Stock Information
  • SEC Filings
  • Analyst Coverage
  • Corporate Governance
    • Governance Documents
    • Board of Directors
    • Committee Composition
  • Stockholder Meeting
  • Email Alerts
  • Investor Contact
Stockholder Meeting

2025

Date: December 16, 2025
Time: 11:00 AM Eastern Time
Live Virtual Meeting Webcast: Click Here

To participate in the Annual Meeting, you must pre-register by 11:00 AM Eastern Time on December 15, 2025.

Agenda
Rules of Conduct
2025 Proxy Statement
Form 10-K Annual Report, Fiscal Year 2024
Form 10-Q Quarterly Report, June 30, 2025
Sample Proxy Card
Get Notified

Sign up to have the latest news and information delivered directly to your inbox!

Sign Up Now

Contact Us

AIM ImmunoTech
2117 SW Highway 484
Ocala, FL 34473
Phone: 352-448-7797
Fax: 352-480-4620
Email: info@AIMimmuno.com

Investor Relations Contact
JTC Team, LLC
Jenene Thomas
908-824-0775
AIM@jtcir.com

©2025 AIM ImmunoTech     All Rights Reserved
  • Privacy Policy
  • Terms of Use
  • Follow
  • Follow
  • Follow